On these grounds, we tested (by luciferase reporter assay) the predicted interactions of miR-125a-5p with three predicted target genes (DIP2A, E2F2, ADD2), all related to mechanisms involved in MS and significantly downregulated in our previous study on PedMS subjects [19]. The gene discussed is E2F2; the disease is myeloid sarcoma.